Everolimus and Abnormal behavior - a phase IV clinical study of FDA data

Summary:

Abnormal behavior is reported as a side effect among people who take Everolimus (everolimus), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Abnormal behavior when taking Everolimus. It is created by eHealthMe based on reports of 16,218 people who have side effects when taking Everolimus from the FDA, and is updated regularly.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,359 drugs and 1,957 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

16,218 people reported to have side effects when taking Everolimus.
Among them, 20 people (0.12%) have Abnormal behavior.

Could Everolimus cause Abnormal behavior?

Among these 20 people:

How long have people been on Everolimus when they have Abnormal behavior? *

What is the gender of people who have Abnormal behavior when taking Everolimus? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Abnormal behavior when taking Everolimus? *

What are other drugs people take besides Everolimus? *

What are other side effects people have besides Abnormal behavior? *

Diarrhea: 10 people, 50.00%
Aggression: 8 people, 40.00%
Hepatic Lesion: 7 people, 35.00%
Fatigue (feeling of tiredness): 6 people, 30.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 30.00%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 30.00%
5-Hydroxyindolacetic Acid Increased (high protein level): 5 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 25.00%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 25.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 5 people, 25.00%

What are the existing conditions these people have? *

Neuroendocrine Tumor: 4 people, 20.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 15.00%
Angiomyolipoma (most common benign tumour of the kidney): 3 people, 15.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 10.00%
Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 2 people, 10.00%
Pneumonia: 1 person, 5.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
Disturbance In Social Behavior: 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Everolimus and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Everolimus:

Everolimus (16,228 reports)

Browse all side effects of Everolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behavior:

Abnormal behavior (1,359 drugs)

Browse all the conditions that are associated with Abnormal behavior:

Abnormal behavior (1,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on everolimus (the active ingredients of Everolimus) and Everolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.